The Global Breast Reconstruction Market Growth Accelerated By Rising Incidence Of Breast Cancer

 

Breast reconstruction is a surgical procedure that creates a breast mound using either autologous tissue or synthetic implants. It is recommended for women who have undergone mastectomy, or breast removal, due to breast cancer or preventative surgeries for high-risk patients. Breast reconstruction offers both physical and psychological advantages for women dealing with breast cancer. The global Breast Reconstruction market is estimated to be valued at US$ 901.3 Mn in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
The rising incidence rate of breast cancer is one of the major factors driving the growth of the breast reconstruction market. According to WHO, breast cancer remains the most common cancer in women globally, with an estimated 2.3 million new cases in 2020. Breast cancer incidence is highest in developed nations, where 1 in 8 U.S. women will develop invasive breast cancer over their lifetime. The increasing awareness about reconstructive breast surgeries after mastectomy and the availability of advanced techniques are encouraging more women to undergo the procedure. Companies are also developing innovative breast implants and tissue expanders to expand the application areas of breast reconstruction.

Segment Analysis
The Global Breast Reconstruction Market Size is dominated by tissue expanders segment which held approximately 40% market share in 2023. Tissue expanders are temporary breast implants used to slowly stretch out the surrounding tissue and skin before a permanent breast implant is placed or before the breast is rebuilt using a patient’s own tissue. Tissue expanders are considered as the first step for two-stage breast reconstruction and as an alternative to direct-to-implant breast reconstruction procedure. Their wide acceptance can be attributed to ability to reconstruct the breast with minimal scars and their effectiveness in size and shape matching of the reconstructed breast with non-reconstructed breast.

North America dominated the global breast reconstruction market and held around 45% of the total market share in 2023. Higher patient awareness regarding breast reconstruction options, product availability, adoption of advanced reconstructive procedures as well as supportive reimbursement policies are some of the key factors contributing to market leadership of North America. Asia Pacific is expected to witness fastest growth over the forecast period 2023-2030 owing to increasing prevalence of breast cancer, improving access to advanced healthcare facilities and rising medical tourism.

Key players operating in the breast reconstruction market are Mentor Medical Systems B.V. (Johnson & Johnson),,Allergan, Inc. (AbbVie),,Sientra, Inc.,,Ideal Implant Incorporated,,Establishment Labs,,POLYTECH Health & Aesthetics GmbH,,RTI Surgical,,Sebbin,,Integra LifeSciences,,GC Aesthetics. Mentor Worldwide LLC (Johnson & Johnson) leads the global breast reconstruction market with wide range of implants and tissue expanders for breast reconstruction. Allergan, Inc (AbbVie) holds second position globally through its breast implants portfolio including NATRELLE INSPIRA SoftTouch breast implants.

For More Insights, Read: https://www.newswirestats.com/breast-reconstruction-market-size-share-and-growth-forecast-2023-2030/